Myriad Genetics to Participate in Upcoming Healthcare Conferences

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN) has announced its participation in key healthcare conferences. Management will present at the BTIG MedTech, Digital Health, Life Sciences and Diagnostic Tools Conference on February 14, 2023. Additionally, they will be featured at the 44th Annual Raymond James Institutional Investors Conference on March 6, 2023, at 11:35 a.m. ET, and the 43rd Annual Cowen Health Care Conference on March 7, 2023, at 10:30 a.m. ET. Live audio webcasts for these presentations will be accessible via Myriad's investor section on their website.

SALT LAKE CITY, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced management will participate at the upcoming healthcare conferences.

• The BTIG MedTech, Digital Health, Life Sciences and Diagnostic Tools Conference on Feb. 14, 2023.

• The 44^th Annual Raymond James & Associates Institutional Investors Conference with a presentation on March 6, 2023, at 11:35 a.m. ET.

• The 43^rd Annual Cowen Health Care Conference with a presentation on March 7, 2023, at 10:30 a.m. ET.
  

The presentations at Raymond James and Cowen will be available through live audio webcast links in the investor information section of Myriad’s website at www.myriad.com.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Myriad, the Myriad logo, BRACAnalysis, BRACAnalysis CDx, Colaris, Colaris AP, MyRisk, Myriad MyRisk, MyRisk Hereditary Cancer, MyChoice CDx, Prequel, Prequel with Amplify, Amplify, Foresight, Precise, FirstGene, SneakPeek, Health.Illuminated., RiskScore, Prolaris, GeneSight, and EndoPredict are trademarks or registered trademarks of Myriad Genetics, Inc. © 2023 Myriad Genetics, Inc. All rights reserved.

Media Contact:	Investor Contact:
Glenn Farrell	Matt Scalo
(801) 584-1153	(801) 584-3532
Glenn.Farrell@myriad.com	Matt.Scalo@myriad.com

FAQ

What healthcare conferences is Myriad Genetics participating in February and March 2023?

Myriad Genetics will participate in the BTIG conference on February 14, 2023, and the Raymond James conference on March 6, 2023, and the Cowen conference on March 7, 2023.

How can I watch Myriad Genetics' presentations at the upcoming conferences?

You can watch Myriad Genetics' presentations via live audio webcasts available on their investor information section at www.myriad.com.

What is the schedule for Myriad Genetics' presentations in March 2023?

Myriad Genetics will present at the Raymond James Conference on March 6, 2023, at 11:35 a.m. ET and at the Cowen Conference on March 7, 2023, at 10:30 a.m. ET.

What is the significance of Myriad Genetics' participation in these conferences?

Myriad Genetics' participation highlights its leadership in genetic testing and precision medicine, offering insights into advancements in health and well-being.